✦ LIBER ✦

PCV39 Cost Assessment of Drugs for Venous Thromboembolism Prevention After Hip or Knee Replacement in Mexican Population

✍ Scribed by I. Contreras; R. Torres-Gonzalez; M.A. Ocegueda-Sosa; V. Hernandez-Cuevas; O.F. Mendoza-Lemus; F. Vilchez-Cavazos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV39 COST-EFFECTIVENESS OF DABIGATRAN E

✍ C Mateus; S Wolowacz; JA Pereira 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCV22 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ Lukac, M; Bielik, J; Lees, M; Foltan, V; Tomek, D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV19 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Chen, XB; Eggington, S; Wang, CY; Zhu, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PCV39 INDIRECT COMPARISONS OF RIVAROXABA

✍ A Diamantopoulos; C LeReun; F Rasul; M Lees; M Kubin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

A systematic review of rivaroxaban versu

✍ Song Turun; Liao Banghua; Yin Yuan; Li Zhenhui; Nie Ying; Chen Jin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 985 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB